Kelvin Kesse
Securities, Public Company and Corporate Law Attorney
I am the founding partner of Kesse PLLC, a corporate law firm. Prior to founding Kesse PLLC, I worked at the biggest law firms in the country.
My practice focuses on securities, capital markets, SEC reporting, emerging companies and startups, and general corporate law. I regularly advise clients on public and private securities offerings and financings, including U.S.-Canadian cross-border offerings and other foreign private issuer offerings. I assist clients with IPOs, Regulation A+ offerings, direct listings, follow-on/secondary offerings, private placements, crowdfunding, private company financings, pre-IPO counseling, SPAC formations, IPOs and business combinations (deSPACs), tender offers, emerging company and startup financings, SEC reporting and compliance and stock exchange listing and compliance.
I work with clients all over the U.S. and internationally.
My representative transactions include the following:
Represented a Nasdaq-listed commercial-stage biotech company in its $345 million IPO, a $244 million follow on offering, and SEC periodic reporting.
Represented a Nasdaq-listed developer of a wearable, non-invasive continuous glucose monitor in its IPO.
Representing a Nasdaq-listed clinical-stage biopharmaceutical company in its $350 million follow-on public offering.
Represented a Nasdaq-listed molecular diagnostics company in its purchase of a private company for approximately $2.15 billion.
Represented a biopharmaceutical company in its $5.35 billion business combination.
Represented a Nasdaq-listed clinical stage immuno-oncology company in its $2.26 billion acquisition by a public company.
Represented a Nasdaq-listed late-stage clinical company in its “At-the-Market” offering and SEC periodic filings.
Represented an NYSE-listed life sciences company focused on biopsy diagnostics for the early detection of cancer in its $40.25 million follow-on offering.
Represented a biotechnology company in its direct listing.
- Business Law
- Business Contracts, Business Dissolution, Business Finance, Business Formation, Mergers & Acquisitions
- Securities Law
- Capital Markets
- Venture Capital
- Emerging Companies and Startups
- Public Company Advisory and Compliance
- SEC Filings
-
Free Consultation
Available for free 30 minute consultation - Credit Cards Accepted
- District of Columbia
- District of Columbia Bar
-
- Massachusetts
- Massachusetts Board of Bar Overseers
-
- North Carolina
- North Carolina State Bar
-
- Texas
- State Bar of Texas
-
- Washington
- Washington State Bar Association
- ID Number: 49770
-
- English: Spoken, Written
- Founding Partner
- Kesse PLLC
- - Current
- I am the founding partner of Kesse PLLC, a boutique corporate law firm. Prior to founding Kesse PLLC, I worked at the biggest law firms in the country. My practice focuses on securities, capital markets, SEC reporting, emerging companies and startups, and general corporate law. I regularly advise clients on public and private securities offerings and financings, and I have significant experience with U.S.-Canadian cross-border offerings and other foreign private issuer offerings. I assist clients with IPOs, Regulation A+ offering, direct listings, follow-on/secondary offerings, private placements, private company financings, pre-IPO counseling, SPAC formations, IPOs and business combinations/deSPACs, tender offers, emerging company and startup financings, all aspects of corporate governance matters, SEC reporting and compliance, and stock exchange initial and additional listing and on-going listing requirements and compliance.
- Senior Associate
- Norton Rose Fulbright
- -
- I was a Business M&A/ Securities Senior Associate at Norton Rose Fulbright's Houston office. I assisted clients with public and private securities offerings; all aspects of corporate governance matters; public company representation; stock exchange initial listing and on-going compliance; and general corporate transactions.
- Associate
- Goodwin Procter LLP
- -
- I was an associate in Goodwin's Business Law Department and a member of its Life Sciences group. I assisted clients with public and private securities offerings (including US-Canadian cross-border transactions and foreign private issuer offerings); all aspects of corporate governance matters; public company representation (including on-going SEC reporting and compliance); stock exchange initial listing and on-going compliance; and general corporate transactions.
- Associate
- K&L Gates
- -
- I assisted clients with public and private securities offerings (and I have significant experience in US-Canadian cross-border transactions); mergers and acquisitions; all aspects of corporate governance matters; SEC reporting and compliance (’33 and ’34 Acts); stock exchange initial listing and on-going listing requirements and compliance; and general corporate transactions.
- Associate
- DLA Piper LLP (US)
- -
- Associate
- Dorsey & Whitney LLP
- -
- Harvard Law School
- J.D. (2015)
- -
- Activities: Submissions Editor, Harvard Business Law Review President, Harvard African Law Association
-
- Texas State Bar # 24134104
- Member
- - Current
-
- Massachusetts State Bar # 710534
- Member
- - Current
-
- DC Bar # 1766479
- Member
- - Current
-
- North Carolina State Bar # 58353
- Member
- - Current
-
- Washington State Bar # 49770
- Member
- - Current
-
- Reverse Mergers: An Alternative Path to Public Listing
- www.kessepllc.com
- SEC Adopts Rule to Increase Transparency into Short Selling
- www.kessepllc.com
- SEC Adopts Rule 10c-1a to Increase Transparency in Securities Lending
- www.kessepllc.com
- Corporate Transparency Act
- www.kessepllc.com
- Website
- Website
